HK1174836A1 - Purification of streptococcus pneumoniae type polysaccharides - Google Patents

Purification of streptococcus pneumoniae type polysaccharides

Info

Publication number
HK1174836A1
HK1174836A1 HK13102016.1A HK13102016A HK1174836A1 HK 1174836 A1 HK1174836 A1 HK 1174836A1 HK 13102016 A HK13102016 A HK 13102016A HK 1174836 A1 HK1174836 A1 HK 1174836A1
Authority
HK
Hong Kong
Prior art keywords
lysate
methods
precipitation
cause
aggregation
Prior art date
Application number
HK13102016.1A
Other languages
English (en)
Chinese (zh)
Inventor
布賴恩．道格拉斯．巴勒爾
埃里克．赫勒．休斯
李初順
Original Assignee
惠氏公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39156240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1174836(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 惠氏公司 filed Critical 惠氏公司
Publication of HK1174836A1 publication Critical patent/HK1174836A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
HK13102016.1A 2006-10-10 2013-02-18 Purification of streptococcus pneumoniae type polysaccharides HK1174836A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85066506P 2006-10-10 2006-10-10

Publications (1)

Publication Number Publication Date
HK1174836A1 true HK1174836A1 (en) 2013-06-21

Family

ID=39156240

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13102016.1A HK1174836A1 (en) 2006-10-10 2013-02-18 Purification of streptococcus pneumoniae type polysaccharides

Country Status (19)

Country Link
US (1) US7659090B2 (ko)
JP (1) JP5260531B2 (ko)
KR (1) KR101467002B1 (ko)
CN (2) CN102648979B (ko)
AT (1) ATE473289T1 (ko)
AU (1) AU2007307800C1 (ko)
BR (2) BR122019021950B8 (ko)
CA (1) CA2665169C (ko)
CL (1) CL2007002909A1 (ko)
DE (1) DE602007007642D1 (ko)
DK (1) DK2074221T3 (ko)
ES (1) ES2346929T3 (ko)
HK (1) HK1174836A1 (ko)
IL (2) IL197782A (ko)
MX (1) MX2009003730A (ko)
PT (1) PT2074221E (ko)
RU (1) RU2460539C2 (ko)
WO (1) WO2008045852A2 (ko)
ZA (1) ZA200902502B (ko)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
DK2385981T3 (da) 2008-12-18 2019-10-21 Wyeth Llc Fremgangsmåde til kontrol af molekylvægt af streptococcus pneumoniae-polysaccharid ved anvendelse af carbon
MX2011006432A (es) 2008-12-18 2011-09-29 Wyeth Llc Metodo para controlar el peso molecular del polisacarido streptococcus pneumoniae serotipo 19a.
CA2756522C (en) 2009-03-24 2018-06-26 Novartis Ag Adjuvanting meningococcal factor h binding protein
RU2555757C2 (ru) 2009-03-24 2015-07-10 Новартис Аг Комбинации менингококкового фактор н-связывающего белка и пневмококковых сахаридных конъюгатов
WO2010125480A1 (en) 2009-04-30 2010-11-04 Coley Pharmaceutical Group, Inc. Pneumococcal vaccine and uses thereof
WO2011161653A1 (en) 2010-06-25 2011-12-29 Novartis Ag Combinations of meningococcal factor h binding proteins
CN102094053B (zh) * 2010-11-26 2013-01-16 兰州生物制品研究所有限责任公司 肺炎链球菌c多糖的纯化方法
BR112013022397A2 (pt) 2011-03-02 2017-09-26 Derek O’Hagan vacinas combinadas com doses menores de antígeno e/ou adjuvante
US10596246B2 (en) 2011-12-29 2020-03-24 Glaxosmithkline Biological Sa Adjuvanted combinations of meningococcal factor H binding proteins
JP2015510872A (ja) 2012-03-07 2015-04-13 ノバルティス アーゲー Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
EP2822584A1 (en) 2012-03-08 2015-01-14 Novartis AG Combination vaccines with tlr4 agonists
CN104602705A (zh) 2012-09-06 2015-05-06 诺华股份有限公司 血清组b脑膜炎球菌和d/t/p的联合疫苗
AU2013313794B2 (en) 2012-09-07 2016-10-20 Sk Bioscience Co., Ltd. Production method for capsular polysaccharide having pneumococcal serotype
CN105007935A (zh) 2012-12-18 2015-10-28 葛兰素史密丝克莱恩生物有限公司 用于保护免于白喉和/或破伤风的缀合物
KR102099741B1 (ko) 2014-01-21 2020-04-10 화이자 인코포레이티드 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PE20161095A1 (es) 2014-01-21 2016-10-26 Pfizer Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos
EP3096786B1 (en) 2014-01-21 2021-07-07 Pfizer Inc. Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PL3244917T3 (pl) 2015-01-15 2023-07-17 Pfizer Inc. Kompozycje immunogenne do zastosowania w szczepionkach przeciwko pneumokokom
EP3288983A1 (en) 2015-04-28 2018-03-07 Biological E Limited Method for separation of protein and other impurities from microbial capsular polysaccharides
IL297740A (en) 2015-05-04 2022-12-01 Pfizer Protein-polysaccharide conjugates of group b streptococcus, methods for preparing the conjugates, immunogenic preparations containing conjugates and their uses
RU2721128C2 (ru) 2015-07-21 2020-05-18 Пфайзер Инк. Иммуногенные композиции, содержащие конъюгированные антигены капсульного сахарида, наборы, содержащие эти композиции, и их применения
CA3005524C (en) 2015-11-20 2023-10-10 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
MX2019001342A (es) 2016-08-05 2019-07-04 Sanofi Pasteur Inc Composicion de conjugado de proteina-polisacarido de neumococo multivalente.
AU2017306708B2 (en) 2016-08-05 2021-08-26 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
JP7186166B2 (ja) 2016-12-30 2022-12-08 バックスサイト・インコーポレイテッド 非天然アミノ酸とのポリペプチド抗原接合体
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
KR102459629B1 (ko) 2017-01-20 2022-10-28 화이자 인코포레이티드 폐렴구균 백신에 사용하기 위한 면역원성 조성물
CN116870144A (zh) 2017-01-31 2023-10-13 默沙东有限责任公司 制备多糖-蛋白缀合物的方法
KR20240011879A (ko) 2017-02-24 2024-01-26 머크 샤프 앤드 돔 엘엘씨 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진
JP7111799B2 (ja) 2017-07-05 2022-08-02 インベントプライズ リミテッド ライアビリティ カンパニー 溶菌酵素、接線流濾過、及びマルチモードクロマトグラフィを用いたワクチン生産のための多糖精製
US10702596B2 (en) 2017-07-05 2020-07-07 Inventprise, Llc Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
AU2018328038B2 (en) 2017-09-07 2024-03-07 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN111093649B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
KR20230130153A (ko) 2017-12-06 2023-09-11 머크 샤프 앤드 돔 엘엘씨 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체를 포함하는 조성물 및 그의 사용 방법
US11896656B2 (en) 2018-04-30 2024-02-13 Merck Sharp & Dohme Llc Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
EP3787673A4 (en) 2018-04-30 2022-04-27 Merck Sharp & Dohme Corp. METHODS FOR PRODUCING CAPSULAR CARRIER PROTEIN-POLYSACCHARIDE CONJUGATES OF STREPTOCOCCUS PNEUMONIAE
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
EP3817775A1 (en) 2018-07-04 2021-05-12 Vaxcyte, Inc. Improvements in immunogenic conjugates
JP2022512345A (ja) 2018-12-12 2022-02-03 ファイザー・インク 免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
US20220296695A1 (en) 2018-12-19 2022-09-22 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
EP3952906A1 (en) 2019-04-10 2022-02-16 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
JP2022542316A (ja) 2019-07-31 2022-09-30 サノフィ パスツール インコーポレイテッド 多価肺炎球菌多糖体－タンパク質コンジュゲート組成物およびその使用方法
US20210070890A1 (en) * 2019-09-06 2021-03-11 Serum Institute Of India Private Limited Method for obtaining purified bacterial polysaccharides
US20230321212A1 (en) 2020-08-26 2023-10-12 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
CA3199094A1 (en) * 2020-10-22 2022-04-28 Pfizer Inc. Methods for purifying bacterial polysaccharides
CN116744965A (zh) 2020-11-04 2023-09-12 辉瑞大药厂 用于肺炎球菌疫苗的免疫原性组合物
EP4243863A2 (en) 2020-11-10 2023-09-20 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2022234416A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against pneumoccocal and covid-19 infections
WO2022234405A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against bacterial and betacoronavirus infections
JP2024522395A (ja) 2021-05-28 2024-06-19 ファイザー・インク コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
US20220387576A1 (en) 2021-05-28 2022-12-08 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2023135515A1 (en) 2022-01-13 2023-07-20 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024084397A1 (en) 2022-10-19 2024-04-25 Pfizer Inc. Vaccination against pneumoccocal and covid-19 infections
WO2024110827A1 (en) 2022-11-21 2024-05-30 Pfizer Inc. Methods for preparing conjugated capsular saccharide antigens and uses thereof
US20240181028A1 (en) 2022-11-22 2024-06-06 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024116096A1 (en) 2022-12-01 2024-06-06 Pfizer Inc. Pneumococcal conjugate vaccine formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413057A (en) * 1980-04-14 1983-11-01 Merck & Co., Inc. Group B streptococcal capsular polysaccharides
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
AR022963A1 (es) * 1999-03-19 2002-09-04 Smithkline Beecham Biolog Vacuna
US6642017B2 (en) * 2000-03-16 2003-11-04 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
US20050220777A1 (en) * 2003-11-21 2005-10-06 Stefan Roos Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
PL3466982T3 (pl) 2005-04-08 2020-11-02 Wyeth Llc Usuwanie zanieczyszczeń z polisacharydu streptococcus pneumoniae poprzez zmianę ph
US8598337B2 (en) * 2006-01-13 2013-12-03 Baxter International Inc. Method for purifying polysaccharides

Also Published As

Publication number Publication date
JP5260531B2 (ja) 2013-08-14
CA2665169C (en) 2017-02-21
IL233893A0 (en) 2014-09-30
DE602007007642D1 (de) 2010-08-19
KR101467002B1 (ko) 2014-12-01
CN101522906A (zh) 2009-09-02
AU2007307800B2 (en) 2012-12-20
CN102648979A (zh) 2012-08-29
AU2007307800C1 (en) 2014-03-13
CN101522906B (zh) 2012-05-30
CA2665169A1 (en) 2008-04-17
JP2010505963A (ja) 2010-02-25
BRPI0717834B8 (pt) 2021-05-25
US7659090B2 (en) 2010-02-09
ATE473289T1 (de) 2010-07-15
MX2009003730A (es) 2009-04-22
RU2009112453A (ru) 2010-11-20
RU2460539C2 (ru) 2012-09-10
AU2007307800A1 (en) 2008-04-17
BRPI0717834B1 (pt) 2020-05-19
PT2074221E (pt) 2010-09-06
IL197782A0 (en) 2011-08-01
KR20090071629A (ko) 2009-07-01
IL233893A (en) 2017-04-30
CL2007002909A1 (es) 2008-04-18
BR122019021950B8 (pt) 2021-07-27
DK2074221T3 (da) 2010-09-06
BRPI0717834A2 (pt) 2014-06-10
BR122019021950B1 (pt) 2021-01-05
US20080102498A1 (en) 2008-05-01
CN102648979B (zh) 2014-05-14
IL197782A (en) 2014-08-31
ZA200902502B (en) 2010-03-31
WO2008045852A3 (en) 2008-06-19
WO2008045852A2 (en) 2008-04-17
ES2346929T3 (es) 2010-10-21

Similar Documents

Publication Publication Date Title
IL233893A0 (en) Purification of polysaccharides of streptococcus pneumoniae type 3
UA99278C2 (ru) Способ получения существенно очищенных капсульных полисахаридов из лизата клеток streptococcus pneumoniae
MX2019005911A (es) Anticuerpos anti_cd137 novedosos y usos de estos.
WO2007011363A3 (en) Binding domain fusion proteins
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
WO2006087637A3 (en) Anti her2/neu antibody
CA2553640C (en) Novel canola protein isolate
ATE537188T1 (de) Serumalbuminbindende proteine
EA201070987A1 (ru) Очищенные гибридные белки иммуноглобулина и способы их очищения
WO2008074840A3 (en) Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
PH12015501705A1 (en) Methods for producing diketopiperazines and compositions containing diketopiperazines
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
AU2017329645A8 (en) Novel antibodies against Factor XI and uses thereof
WO2008033556A3 (en) High pressure treatment of proteins for reduced immunogenicity
WO2009043922A3 (en) Extracellular targets for alzheimer's disease
MY148837A (en) Hydrolysed egg proteins
IL218442A0 (en) Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
WO2005021575A3 (en) Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
CN104774822A (zh) 幽门螺旋杆菌丝氨酸蛋白酶的制备方法
Zhao et al. Deamidization and double enzyme synergetic hydrolysis increasing hydrolysis effeciency of wheat gluten
TW200745337A (en) Modified process
Mohamad Sait Determination of stem bromelain activity from pineapple plant (ananas comosus)
Park et al. Application of enzymatic transglycosylation via recombinant Sulfolobus shibatae β-glycosidase to produce new sucrose derivative
Sripuan Purification, characterization and application of-Galactosidase from Ling-zhi mushroom (Ganoderma lucidum)
CN106834333A (zh) 一种能高效表达中性蛋白酶的质粒、其构建方法及其应用